parthenolide has been researched along with quercetin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Avonto, C; Avula, B; Khan, IA; Khan, SI; Smillie, TJ; Vasquez, Y; Wang, M; Wang, YH; Yang, MH; Zhao, J | 1 |
| Amrutha, K; Banerji, A; Nanjan, P; Rajakrishna, L; Shaji, SK; Subhalakshmi, K; Sunilkumar, D | 1 |
| Castro, V; García-Piñeres, AJ; Merfort, I; Mora, G; Pahl, HL; Schmidt, TJ; Strunck, E | 1 |
| Guzdek, A; Koj, A; Rokicki, M; Stalińska, K | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
8 other study(ies) available for parthenolide and quercetin
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Octulosonic acid derivatives from Roman chamomile (Chamaemelum nobile) with activities against inflammation and metabolic disorder.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chamaemelum; Flowers; Hypoglycemic Agents; Mississippi; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Nuclear Magnetic Resonance, Biomolecular; Oxidative Stress; PPAR alpha; PPAR gamma; Sugar Acids | 2014 |
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Drug Discovery; Flavones; Humans; Molecular Structure; NF-kappa B; Signal Transduction; Structure-Activity Relationship | 2014 |
Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cysteine; DNA-Binding Proteins; Drug Design; I-kappa B Proteins; Lactones; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Binding; Protein Subunits; Quercetin; Sesquiterpenes; Transcription Factor RelA | 2001 |
Transcription factors as targets of the anti-inflammatory treatment. A cell culture study with extracts from some Mediterranean diet plants.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Cells, Cultured; Curcumin; Diet, Mediterranean; Electrophoretic Mobility Shift Assay; Endothelial Cells; Humans; Interleukin-1; Interleukin-6; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Plant Extracts; Quercetin; Sesquiterpenes; STAT Transcription Factors; Transcription Factor AP-1 | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |